Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 331NIH 127INDUSTRY 53NETWORK 42UNKNOWN 3OTHER_GOV 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Nasopharyngeal Carcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Taxes × Clear all
NCT07057427 2025-07-09

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
812 enrolled
Breast

Breast Neoplasms

NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase 2 Not yet recruiting
39 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT02707159 2023-03-08

PACT-ACT-v6

Helse Stavanger HF

Phase 2 Completed
70 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡